share_log

Exscientia Will Expand Its Work With Amazon Web Services Using The Cloud Provider's Artificial Intelligence And Machine Learning Services To Power Its Platform For End-To-End Drug Discovery And Automation

Benzinga ·  Jul 10 07:18

The platform, built using Amazon Web Services technologies, integrates generative AI drug design and robotic lab automation to further accelerate Exscientia's ability to deliver high quality drug candidates at faster speed and lower cost.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment